+
Site Tour

Search

Showing 81 - 90 of 463 results.

  • 404 - Page not found

    404 Page not found The location may have changed Please double-check the web address, look for your topic via search or look at our sitemap.  
  • Clinical Data

    MitraClip™ + GDMT patients were more likely to be in NYHA functional class I or II throughout the 5 years MitraClip™ + GDMT patients benefited from a 47% relative risk reduction in HFH/ Death versu
  • Survey

    © Abbott 2024. All rights reserved. 9-EH-8-15474-01 08-2024
  • Guidelines & Recommendations

    Compelling data resulted in positive guidelines recommending PFO closure Long-term data from the both the RESPECT trial12 and REDUCE trial,13 as well as data from the CLOSE trial,14 have revealed tha
  • Guidelines

    2024 EUROPEAN SOCIETY OF CARDIOLOGY (ESC) GUIDELINES FOR THE MANAGEMENT OF ATRIAL FIBRILLATION DEVELOPED IN COLLABORATION WITH THE EUROPEAN ASSOCIATION OF CARDIOTHORACIC SURGERY (EACTS)4-7 ACCESS TO
  • Guidelines & Recommendations

    SWITCH TO THE interventional VIEW    For more information specific to interventional cardiology regarding LAA Occlusion 2024 EUROPEAN SOCIETY OF CARDIOLOGY (ESC) GUIDELINES FOR THE MANAGE
  • Guidelines

    Summary of current relevant international guidelines on the diagnosis of TR TR should be evaluated first by echocardiography. In primary TR, specific abnormalities of the valve can be identified.
  • Surgical Repair or Replacement

    Topilsky Y, Maltais S, Medina Inojosa J et al. Burden of tricuspid regurgitation in patients diagnosed in the community setting. JACC Cardiovasc Imaging. 2019;12(3):433–442. https://doi.org/10.1016
  • Diagnosis

    AF AND STROKE ARE OFTEN CONNECTED MORE SEVERE FIND OUT MORE: PATIENTS WHO BENEFIT Clinical Data
  • Overview

    Fuster V, Rydén LE, Cannom DS, et al. ACC/AHA/ESC Practice Guidelines for the Management of Patients with Atrial Fibrillation. Circulation. 2006;114(7):700–752. https://doi.org/10.1161/CIRCULATIO

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline